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 Background aims 
 Several authors have demonstrated that adipose tissue contains 
multipotent cells capable of differentiation into several lineages, 
including bone, cartilage and fat. 
 Methods 
 This study compared human adipose-derived stem cells (hASC) 
isolated from 26 female donors, under 35 and over 45 years old, 
showing differences in their cell numbers and proliferation, and 
evaluated their in vitro  adipocytic and osteoblastic differentiation 
potential. 
 Results 
 The cellular yield of hASC from older donors was signifi cantly 
greater than that from younger donors, whereas their clonogenic 
potential appeared slightly reduced. There were no signifi cant 
discrepancies between hASC isolated from young and elderly women 
regarding their in vitro  adipocytic differentiation, whereas the 
osteoblastic potential was signifi cantly reduced by aging. We also 
assessed the infl uence of hydroxyapatite (HAP) and silicon carbide 
(SiC–PECVD) on hASC. Even when cultured on scaffolds, hASC 
from younger donors had better differentiation into osteoblast-like 
cells than hASC from older donors; their differentiation ability was 
up-regulated by the presence of HAP, whereas SiC–PECVD 
produced no signifi cant effect on hASC osteoblastic differentiation. 
 Conclusions 
 The large numbers of hASC resident in adipose tissue and their 
differentiation features suggest that they could be used for a 
successful bone regeneration process in vivo . We have shown that 
age does not seem to affect cell viability and in vitro  adipocytic 
differentiation signifi cantly, whereas it does affects osteoblastic 
differentiation, in the absence and presence of two-dimensional and 
three-dimensional scaffolds. 
 Keywords 
 Aging,  ex vivo expansion,  human adipose-derived stem cells, 
 multipotential differentiation,  osteoprogenitor cells,  tissue regeneration. 
 Introduction 
 Because of a low self-regenerative faculty, bone and 
cartilage defects caused by trauma, tumors and congenital 
defi ciency never restore spontaneously. Innovative musculo-
skeletal regeneration approaches include tissue-engineering 
techniques using adult mesenchymal stromal cells (MSC) 
[ 1 – 10 ]. Bone marrow (BM), muscle, synovial membrane 
and adipose tissue are sources of MSC [ 11 – 14 ]. It is known 
that adipose tissue changes during life, together with a 
coordinated remodeling of the adipose vascularization [ 15 ]; 
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these modifi cations are mediated by resident stem cells [ 15 ]. 
Many authors have shown that these multipotent cells 
share quite similar features with BM stromal cells (BMSC) 
[ 13 , 16 , 17 ]; indeed, human adipose-derived stem cells 
(hASC) are clonogenic, proliferate easily and their proge-
nies show a broad multilineage differentiation potential 
[ 18– 21 ]. Furthermore, hASC proliferation and differentia-
tion do not appear to be negatively affected by donor age, in 
contrast to reports on BMSC [ 22 , 23 ]. Compared with 
other adult tissues, adipose tissue has several advantages 
for both research purposes and clinical applications: a 
minimally invasive procedure is required for tissue with-
drawal and a large number of multipotent cells can be 
isolated rapidly. 
 Musculoskeletal tissue regeneration often requires the 
combination of cells and scaffolds. The ideal material 
should be bio-degradable or bio-absorbable, suitable 
for cellular adhesion, and not induce infl ammatory and 
immunologic responses [ 2 ]. In particular, in bone tissue 
engineering, the biomaterial should provide biomechanical 
support until tissue regeneration is completed and, during 
this process, the scaffold needs to disappear progressively 
to allow new tissue formation and cell colonization. 
Loading stem cells on scaffolds  in vitro before implantation 
may lead to a faster bone formation and osteointegration 
in vivo [ 24 , 25 ]. 
 We compared hASC isolated from female donors who 
were under 35 and over 45 years old, and examined their 
 in vitro adipocytic and osteoblastic differentiation potential. 
We also investigated the infl uence of natural and synthetic 
scaffolds on hASC osteoblastic differentiation. 
 Methods 
 Isolation and culture expansion of hASC 
 The study was carried out after institutional review board 
approval. Subcutaneous fat was obtained from 26 healthy 
female donors [age range 21–68 years, body mass index 
(BMI)  30, without any pathologic obesity] undergoing 
plastic surgery by elective lipoaspiration, after written 
consent. Primary cultures of the stromal vascular fraction 
(SVF) were established as described previously [ 13 ]. Briefl y, 
the raw lipoaspirates (50–100 mL) were washed at least 
three times with phosphate-buffered saline (PBS); the 
matrix was then enzymatically digested with 0.075% type I 
collagenase (Worthington, Lakewood, NJ, USA) at 37°C 
with continuous agitation for 30 min. The SVF was then 
centrifuged (1200 g, 10 min) and fi ltrated through a sterile 
medication lint. The collected SVF cells were plated in con-
trol medium [Dulbecco’s modifi ed Eagle medium (DMEM) 
 10% fetal bovine serum (FBS) supplemented with 50 U/mL 
penicillin, 50 μg/mL streptomycin and 2 mm l-glutamine] at 
approximately 10 5 cells/cm 2 . The cells were maintained at 
37°C in a humidifi ed atmosphere with 5% CO 2 . After 48 h 
non-adherent cells were removed and the medium was 
changed every other day. Adherent cells were grown until 
80% confl uence, detached with 0.5% trypsin/0.2% EDTA 
(Ethylene Diamine Tetraacetic acid), and replated at a 
density of 10 4 cells/cm 2 for further analyzes. 
 For the raw fat manipulation study, lipoaspirates were 
separated into two experimental groups, ‘fi ltered’ and ‘cen-
trifuged’, according to the intra-operative manipulation 
procedure, as described previously [ 26 – 28 ]. The hASC 
isolation was performed as described above. 
 Fibroblast and osteoblast colony-forming unit assays 
 A colony-forming unit–fi broblast (CFU-F) assay was 
performed as described previously [ 29 ] with minor modifi -
cations. hASC were plated in six-well plates at low density 
by limiting dilution (starting dilution 48 cell/cm 2 , ending 
dilution 1 cell/cm 2 ) and cultured at 37°C in a humidifi ed 
atmosphere with 5% CO 2 in DMEM/20%FBS. After 
6 days the medium was replaced, and 10 days after cells 
were fi xed with methanol and stained with Gram’s crystal 
violet. The frequency of CFU-F was established by scoring 
the individual colonies and expressed as a percentage 
relative to the seeded cells. 
 A colony-forming unit–osteoblast (CFU-O) assay was 
performed by plating cells in six-well plates by limiting 
dilution and culturing at 37°C in osteogenic medium (as 
described below) for 14 days. Colonies were then stained 
with Alizarin Red S (pH 4.1). 
 Cell lineage differentiation and evaluation of 
differentiation markers 
Osteoblastic differentiation 
 10 4 hASC/cm 2 were induced to differentiate on monolayer 
in osteogenic medium consisting of control medium supple-
mented with 10 mm glicerol-2-phosphate, 10 nm dexame-
thasone, 150 μm l-ascorbic acid-2-phosphate and 10 nm 
cholecalciferol. After 14 days of differentiation, alkaline 
phosphatase activity (ALP) was determined (Triton X-100 
0.1% in ddH 2 O as lysis buffer) using 1 mm p-nitrophe-
nylphosphate in alkaline buffer (100 mm diethanolamine 
and 0.5 mm MgCl 2 , pH 10.5) as substrate [ 30 ] and normalized 
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for protein content, determined using a BCA protein assay kit 
(Pierce Biotechnology, Rockford, IL, USA). The ALP assay 
was performed at 37°C and absorbance was read at 405 nm 
(Wallac Victor II, Perkin Elmer Western Europe, Monza, 
Italy). To evaluate calcium deposition, 10 4 cells/cm2 were cul-
tured for 21 days with out any cell detachment then samples 
rinsed with PBS and fi xed with ice-cold 70% ethanol for 1 h. 
They were stained with 40 mm Alizarin Red S (pH 4.1) for 
15 min and fi nally rinsed with ddH 2 O. Each sample was 
destained for 30 min with 10% cetylpyridinium chloride 
monohydrate (CPC) in 0.1 m phosphate buffer (pH 7.0) and 
the absorbance read at 550 nm (Wallac Victor II) [ 31 ]. All 
steps were performed at room temperature (RT). 
 Adipocytic differentiation 
 10 4 hASC/cm 2 were induced to differentiate into the 
adipogenic lineage using a pulsed induction comprising 
48 h in control medium supplemented with 1 μm dexame-
thasone, 10 μg/mL insulin, 500 μm 3-isobutyl-1-methyl-
xanthine (IBMX) and 200 μm indomethacin, followed by 
48 h maintenance in control medium supplemented only 
with 10 μg/mL insulin. After 14 days, samples were rinsed 
and fi xed in 10% neutral buffered formalin for 1 h and 
stained with fresh Oil Red O solution (2% w/v Oil Red O 
in 60% isopropanol) for 15 min. To quantify the lipid vacu-
ole content, the dye was extracted with 100% isopropanol 
and absorbance was read at 490 nm. 
 PPAR-γ (Peroxisome Proliferator-Activated Receptor) 
expression of 14-day adipogenic differentiated hASC was 
evaluated by Western blot. Cells were collected by centrif-
ugation, and the cell pellet resuspended in lysis buffer 
(50 mm Tris, pH 8, 150 mm NaCl, 1% Nonidet P40, 0.1% 
SDS) containing proteinase inhibitors and incubated at 
4°C for 30 min. Following centrifugation at 14,000 g 
for 10 min, the supernatant containing total cell extract 
was collected and kept at –20°C. The protein concentra-
tion of cell lysates was measured using a Pierce protein 
assay (Pierce). After boiling for 5 min, 15 μg protein 
were loaded on 10% sodium dodecyl sulfate (SDS)–
polyacrylamide gel (PAGE) and electrotransferred onto 
Hybond™–ECL™ extra nitrocellulose membrane (Amersham 
Bioscience, Pittsburgh, PA). After blocking in 5% non-fat 
dry milk in TBS (Tris Buffer Solution) and 0.1% Tween-20 
(TBST) for 1 h at RT, the membrane was incubated with 
rabbit anti-PPAR-γ (Santa Cruz Biotechnology Inc., Santa 
Cruz, CA, USA) and mouse anti-β -actin (Sigma Aldrich, 
Milan, Italy), diluted at 1:500 and 1:3000, respectively, in 
blocking buffer at 4°C overnight. This was followed by 
incubation with horseradish peroxidise (HRP)-conjugated 
secondary antibodies (GE Healthcare, Pittsburgh, PA) 
for 1 h at RT. Protein visualization was performed using 
the ECL™ Western blotting analysis system kit (GE 
Healthcare, Pittsburgh, PA) according to the manufacturer’s 
protocol. The images were then analyzed with ImageJ. 
 hASC–scaffold constructs 
 10 5 undifferentiated hASC were seeded on porous (60%) 
hydroxyapatite blocks (HAP) (Finceramica, Faenza, Italy) 
and silicon carbide–plasma-enhanced chemical vapor deposi-
tion (SiC–PECVD) fragments (kindly provided by Galileo 
Avionica, Carsoli, Italy). Cells were allowed to adhere 
overnight to scaffolds in a polypropylene vial, then trans-
ferred to a 24-well plate and cultured in static conditions 
for 14–21 days. The SiC–PECVD samples were assessed 
for ALP activity after 14 days of differentiation and for 
calcium deposition after 21 days; ALP activity at 14 and 
21 days was evaluated for HAP samples. 
 Statistical analysis 
 All results are expressed as mean   SD. Student’s  t -test 
and two-way ANOVA (with Bonferroni’s post-test) were 
performed to analyze data;  P -values to be considered were 
∗ P  0.05, ∗∗ P  0.01 and ∗∗∗ P  0.001. 
 Results 
 Features of hASC derived from under 35- and 
over 45-year-old female donors 
 hASC were isolated from liposuction of abdominal 
subcutaneous adipose tissue aspirates from 26 female 
donors. We analyzed the progenitor cell numbers and 
clonogenic potential of hASC derived from females under 
35 years old ( n  12, mean age 31  4 years) and over 
45 years old ( n  14, mean age 56  7 years). We isolated an 
average of 2.7  1.3  10 5 hASC/mL raw adipose tissue 
from the younger donors, in contrast to 6.1  4  10 5 from 
the older donors, as shown in  Figure 1A . Despite the large 
fl uctuations among samples derived from the over 45-year-
old group, as shown in the scatter dot-plot in  Figure 1B , 
the cellular yield turned out to be signifi cantly different 
between the two groups ( P  0.007). However, this broad 
variation did not correlate with donor age within the 
group (data not shown). CFU-F assays were also per-
formed ( Figure 1A ). At earlier passages, hASC from both 
groups were able to produce colonies, although cells from 
younger donors showed a two-fold increase in clonogenic 
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 hASC from younger and older donors show no 
signiﬁ cant differences in their in vitro adipocytic 
differentiation potential 
 We evaluated the hASC adipocytic differentiation potential 
by comparing the amount of lipid vacuoles produced by 
several samples of adipogenic-differentiated hASC 
( Figure 3A , B ). As shown in  Figure 3A , signifi cant Oil Red 
O staining was observed in adipogenic-differentiated cells. 
The  in vitro adipocytic differentiation potential of younger 
and older donors was not statistically different, although the 
increase in lipid content of differentiated hASC was 140% 
and 360% for cells derived from under 35- and over 
45-year-old donors, respectively ( n  5,  P  0 . 05). This 
apparent discrepancy was because of a lower level of 
undifferentiated cells derived from older donors ( Figure 3B ). 
 PPAR-γ expression in undifferentiated and adipogenic-
differentiated hASC was analyzed ( Figure 3C ). PPAR-γ 
was expressed both in undifferentiated and adipogenic-
differentiated cells, with an up-regulation of about 35% in 
the differentiated samples from both age groups ( n  4, 
 P  0 . 05). However, no signifi cant difference in PPAR-γ 
expression of differentiated hASC between the two groups 
was detected. 
 Comparison of hASC isolated from differently 
manipulated adipose tissue 
 We also compared hASC isolated from subcutaneous 
adipose tissue manipulated by either Coleman’s method 
activity. This trend was maintained during passages, whereas 
hASC from older donors lost their clonogenic ability sooner 
(data not shown) [ 32 ]. We then assessed the presence of 
osteoblast-forming units in hASC derived from the two age 
groups at the second passage. About 30% of cells able to 
form fi broblast colonies generated CFU-O. However, we 
did not observe any signifi cant differences between CFU-O 
produced by hASC from younger and older donors. 
 We assayed specifi c MSC markers (CD13, CD14, CD29, 
CD34, CD44, CD45, CD49d, CD54, CD71, CD90 
and CD105) by fl ow cytometric analysis. Comparing 
these data with previously published data [ 33 , 34 ], no 
signifi cant variations related to donor age were observed 
(data not shown). 
 hASC differentiation potential 
 hASC were induced to differentiate towards adipocyte- 
and osteoblast-like cells. Two weeks in differentiating cul-
ture conditions showed signifi cant morphologic changes 
( Figure 2B ,  C ,  E , F ) compared with undifferentiated hASC 
( Figure 2A ,  D ). The classic fi broblastoid-like shape of 
undifferentiated hASC was progressively lost when cells 
were maintained in adipogenic and osteogenic media; 
hASC became either larger, with a cytoplasm full of lipid 
vacuoles, or less outstretched, with an indented cellular 
membrane, respectively. We did not observe any relevant 
morphologic variations among all the older and younger 
derived hASC. 
 Figure 1.  Comparison of cell number and clonogenicity of hASC derived from two groups of females (under 35 and over 45 years old). 
(A) Cellular yield is expressed as the average of hASC/mL of raw lipoaspirates  SD. CFU-F and CFU-O frequencies are expressed as a 
percentage (number of colonies/number of plated cells)  SD. A two-tailed Student’s t -test was performed: ** P  0.01. (B) The cellular yield 
variability between the two experimental groups is represented by a scatter dot-plot; each donor’s yield is represented as a dot, with the mean 
(dotted line) and 95% confi dence interval shown. 
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not infl uence progenitor cell number and their adipocytic 
differentiation ability. 
 Donor age mildly affects hASC in vitro 
osteoblastic differentiation potential 
 hASC from younger donors cultured in osteogenic differen-
tiating medium for 14 days showed a higher ALP  activity 
 compared with cells from older donors ( n  5,  P  0.001) 
 ( Figure 5A ). Indeed, differentiated cells from the younger 
group showed an increase in ALP activity of 280% with re spect 
to undifferentiated ones, whereas the increase was just 40% for 
hASC derived from the over 45-year-old group. Moreover, 
the ALP basal level in undifferentiated hASC derived from 
young er donors was three-fold higher than from older donors. 
 These observations were partially confi rmed by quanti-
fi cation of calcium deposition: cells from the under 35-year-
old group produced a greater amount of calcium deposits 
compared with cells from the over 45-year-old group 
 ( Figure 5B ). However, the great variability among donors 
meant no signifi cant difference between the two groups 
( n  5). The increase in extracellular calcium formation by 
differentiated hASC was 220 and 73% from younger and 
older donors, respectively. 
[ 28 , 35 ] or fi ltration, as described by others [ 26 , 27 ]. Abdo-
minal subcutaneous adipose tissue from four women 
belonging to the over 45-year-old group (mean age 
57  11) was both fi ltered and centrifuged directly in the 
surgery room and then hASC isolated. Immediately 
after isolation, 5.73  1.51  10 5 hASC/mL from fi ltered 
tissues (FILT-hASC) and 6.1  2.41  10 5 hASC/mL from 
centrifuged tissues (CENT-hASC) were obtained, indi-
cating that  different tissue manipulations did not affect 
the yield of progenitor cells. At passage 1, we counted 
2.36  1.1  10 5 FILT-hASC/mL of digested tissue, and 
4.6  3.3  10 5 CENT-hASC, suggesting that centrifuga-
tion may be less traumatic and cells may recover faster, 
although the  difference was not statistically signifi cant. In 
addition, no difference in cellular proliferation was 
observed, and both FILT-hASC and CENT-hASC 
showed similar clonogenic activities, of 8  2 and 6  2%, 
respectively. As shown in  Figure 4 , different cell popula-
tions (hASC-1 and hASC-2) showed great variability in 
their  in vitro adipocytic differentiation; however, within 
each population no signifi cant differences were observed 
between FILT-hASC and CENT-hASC, suggesting that 
the intrasurgery room manipulation of adipose tissue does 
 Figure 2.  Morphology of cultured hASC. Hematoxylin-stained hASC from donors under 35 years old (upper line) and over 45 years old 
(lower line) were cultured in control (A, D), adipogenic (B, E) and osteogenic (C, F) differentiation media (100 ). 
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 As shown in  Figure 5A , even when cultured on HAP, the 
ALP activity of hASC from younger donors, differentiated 
for either 14 and 21 days, was signifi cantly increased com-
pared with the one determined in cells from older donors, 
with an increase of about 10-fold ( Figure 6A ,  B ) ( P  0.001). 
Comparing the ALP activity on the plastic (polystyrene; 
PS) and scaffold, we observed osteoinductive properties of 
 Scaffolds may affect hASC in vitro osteoblastic 
differentiation 
 hASC cultured on scaffolds were analyzed ( Figures 6 and  7 ). 
Their osteoblastic differentiation ability in the presence of 
HAP scaffolds was monitored by ALP assay only, as the 
amount of calcium produced by cells could be masked by 
the calcium released by HAP. 
Figure 3. Adipocytic differentiation of hASC derived from donors under 35 and over 45 years old. (A) Microphotographs (40  ) of 
undifferentiated (left) and adipogenic-differentiated (right) hASC stained with Oil Red O after 14 days of culture. (B) Quantifi cation of 
lipid deposition in undifferentiated (CTRL, white bars) and adipogenic-differentiated hASC for 14 days (ADIPO, fi lled bars) in both age 
groups; data are expressed as mean  SD (n  5). (C) PPAR-γ expression in younger and older donors. Western blot analysis of two populations 
for each group (upper line) and quantifi cation of PPAR-γ expression standardized on  β -actin content; data are expressed as mean  SD 
(n  4). A two-way ANOVA (with Bonferroni’s post-test) was performed: *P  0.05, ADIPO versus CTRL.
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cultured on PS and SiC–PECVD ( Figure 7A ). These data 
were confi rmed by quantifi cation of calcium deposition 
( Figure 7B ): there was no signifi cant difference in extracel-
lular calcifi ed matrix production between cells cultured on 
PS and SiC–PECVD derived from both age groups. Also, 
donor age negatively infl uenced the osteoblastic marker 
expression analyzed ( P  0 . 001) ( Figure 7A ,  B ). 
 Discussion 
 Although BM provides an important source of MSC, 
 adipose tissue also possesses abundant and easily accessible 
progenitor cells. The harvesting procedure for adipose  tissue 
is less invasive and discomfort for a patient is minimal. More-
over, fat may have a further advantage when the morbidity 
associated with large volumes of BM harvest is taken into 
consideration [ 36 ]. In this study, we analyzed and compared 
hASC harvested from female donors aged under 35 and over 
45 years. The signifi cantly more abundant hASC yield per 
milliliter of raw lipoaspirate from the over 45-year-old donors 
may be related to the hormonal disequilibrium in this period 
of a woman’s life, which may enhance the number of 
progenitor mesenchymal cells in adipose tissue, known to 
increase with age. On the other hand, the number of CFU-F 
was just slightly reduced from older donors. No signifi cant 
differences were detected in terms of the  in vitro adipocytic 
differentiation potential of hASC from younger or older 
donors; indeed, in both cases cells were able to differentiate 
into adipocyte-like cells ( Figure 3 ). On the other hand, age 
infl uenced the hASC  in vitro osteoblastic differentiation 
HAP on hASC; indeed, ALP levels of hASC from both 
younger and older donors cultured on HAP were signifi -
cantly higher compared with those maintained on PS 
 ( Figure 6A ,  B ). 
 The infl uence of another scaffold on the osteoblastic 
differentiation ability of hASC was assessed by culture on 
SiC–PECVD, a two-dimensional (2-D) metallic scaffold 
( Figure 7 ). SiC–PECVD did not show any particular 
osteoinductive property: no signifi cant difference in ALP 
activity was detected from cells derived from both groups 
Figure 4. Comparative study of adipocytic-differentiation potential 
of hASC isolated from two donors ( from the over 45-year-old 
group) differently manipulated in the surgery room (FILT, fi ltered; 
CENT, centrifuged). A two-way ANOVA (with Bonferroni’s post 
test) was performed: ∗P  0.05, ∗∗P  0.01, ∗∗∗P  0.001, ADIPO 
versus CTRL.
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Figure 5. Osteoblastic differentiation of hASC derived from donors under 35 and over 45 years old. (A) ALP activity, in undifferentiated 
hASC and osteogenic-differentiated hASC for 14 days. Data are normalized with respect to protein content and expressed as mean  SD 
(n  5). (B) Quantifi cation of calcium deposits in undifferentiated and osteogenic-differentiated hASC for 21 days. Alizarin Red S-stained 
samples were extracted with CPC; data are expressed as mean  SD (n  5) (CTRL, white bars; OSTEO, fi lled bars). A two-way ANOVA 
(with Bonferroni’s post-test) was performed: **P  0.01, ***P  0.001, OSTEO versus CTRL; §§§P  0.001, UNDER 35 years old versus 
OVER 45 years old.
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terms of osteoblastic differentiation potential between 
younger and older donors is related to the intrinsic osteo-
blastic capacity of each single hASC or its differentiation 
rapidity, as we based our evaluation on early osteogenic 
markers. Certainly, this aspect needs further investigation to 
understand better the relationship between osteoprogenitor 
cell density and their effective osteoblastic potential. 
 Hence our data suggest the potential use of autologous 
hASC, although interindividual differences related to sex, 
age and tissue infl ammatory state [ 37 ] need to be taken into 
account for regenerative medicine application, together with 
potential; a reduced differentiation capacity of cells derived 
from female donors over 45 years of age was observed, as 
assessed by ALP activity and calcium deposition. 
 Despite the observed differences in terms of osteoblastic 
marker expression between cells from younger and older 
donors, the osteoprogenitor density was comparable between 
the two age groups, as assessed by CFU-O assay performed 
on hASC at the second passage, when we usually start to dif-
ferentiate them into the osteoblastic lineage. This result is 
interesting, although apparently contradictory; from our 
data, we could hypothesize that the observed difference in 
Figure 6. Infl uence of HAP on in vitro osteoblastic differentiation of hASC belonging to the two age groups. ALP activity, in undifferentiated 
(CTRL, white bars) and osteogenic-differentiated (OSTEO, fi lled bars) hASC, from (A) the under 35-year-old and (B) the over 45-year-
old groups cultured for 14 and 21 days on PS and HAP (patterned bars). Data were standardized with respect to protein content and 
expressed as mean  SD (n  3). A two-way ANOVA (with Bonferroni’s post-test) was performed: *P  0.05; **P  0.01; ***P  0.001, 
OSTEO versus CTRL; $P  0.05, $$P  0.01, $$$P  0.001, HAP versus PS.
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Figure 7. Infl uence of SiC–PECVD on in vitro osteoblastic differentiation of hASC belonging to the two age groups. (A) ALP activity, in 
undifferentiated (CTRL, white bars) and osteogenic differentiated (OSTEO, fi lled bars) hASC cultured for 14 days on PS and SiC–PECVD 
(patterned bars). Data were standardized with respect to protein content and expressed as mean  SD (n  3). (B) Quantifi cation of calcium 
deposits in undifferentiated and osteogenic-differentiated hASC cultured for 21 days on PS and SiC–PECVD. Alizarin Red S-stained 
samples were extracted with CPC; data are expressed as mean  SD (n  3). A two-way ANOVA (with Bonferroni’s post-test) was performed: 
***P  0.001, OSTEO versus CTRL; §§P  0.01, §§§P  0.001, UNDER 35 years old versus OVER 45 years old.
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spanning the withdrawal of adipose tissue progenitor cell 
isolation and its application for the generation of constructs 
available for tissue engineering. With this assumption, we 
seeded undifferentiated hASC on the two different types of 
scaffold and then compared their ability to differentiate into 
osteoblast-like cells with cells cultured on PS. Osteogenic 
induction was assessed by comparing ALP activity and cal-
cium deposit formation of hASC differentiated on biomaterials 
and PS. hASC from younger donors, when cultured on both 
HAP and SiC–PECVD, produced higher ALP activity and a 
greater amount of calcium deposition compared with cells 
derived from older donors ( Figures 6 and  7 ). 
 As expected, HAP showed a strong and direct osteoinduc-
tive effect on hASC; indeed, cells derived from both young 
and old donors, when cultured on HAP, showed greater ALP 
activity compared with cells grown on PS, even if maintained 
in control medium. This result is quite interesting as it shows 
that an enhanced osteogenic effect may also be observed 
 in vitro on hASC, and it may be because of the combined 
effects of the biomaterials and some biochemical signals, 
provided by the medium, and the cells themselves. 
 In conclusion, we have shown that hASC isolated from 
donors under 35 years old and over 45 years old effi ciently 
differentiate towards adipocyte-like cells  in vitro , whereas 
aging seems to affect their osteoblastic differentiation 
potential as assessed  in vitro during a short differentiation 
period. These results were confi rmed by experiments 
performed on scaffolds in static conditions. 
 Because of the high frequency of progenitor cells in 
subcutaneous adipose tissue, which may also be withdrawn 
easily, we believe that ASC are a suitable tool for musculo-
skeletal tissue regeneration. Hence liposuction, now just an 
aesthetic surgery procedure, may become an additional 
method for autologous progenitor cell collection. 
 Further analyzes, such as dynamic culture conditions 
and  in vivo pre-clinical models, need to be tested to probe 
these new observations. In addition, as it is well known that 
hASC may generate endothelial cells [ 45 , 46 ], they theore-
tically may be induced to differentiate towards both endo-
thelial and osteoblastic lineages, promoting a simultaneous 
neovascularization of regenerating bone. 
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the opportune indications for this kind of treatment. 
Aspirated fat is usually used as a fi ller material and autolo-
gous fat transfer is the most used method for soft-tissue 
augmentation, performed without detectable scarring on 
either the donor or recipient site and with very rewarding 
clinical results [ 38 , 39 ]. Fat tissue has been used as fi ller for 
more than 100 years [ 40 ], and different purifi cation 
 techniques have been developed. Currently the most 
common fat-processing methods are fi ltering [ 26 , 27 ] and 
 centrifuging [ 28 , 35 ]. We compared the adipose-derived 
progenitor cells isolated from four middle-aged women 
who had undergone aesthetic surgical intervention and 
processed by both centrifuging and fi ltering. We observed 
no signifi cant differences in terms of hASC viability, 
even though we noticed a slightly broader cell number 
variability for CENT-hASC. The centrifugation process 
may be less traumatic. At early passages, the CENT-hASC 
proliferated faster than the FILT-hASC; however, this 
difference was not statistically signifi cant, because of the 
previously described variability. 
 Our results indicate that fat progenitor cell commitment is 
maintained in both types of manipulated cells, as they are able 
to differentiate effi ciently into adipocytes, confi rming clinical 
reports where both isolation procedures provide progenitor 
cells able to contribute to defect remodeling [ 26 , 27 , 28 , 35 ]. 
 As the use of MSC in regenerative medicine applications 
requires tissue engineering skills [ 41 , 42 ], and the selection 
of a suitable scaffold is fundamental in order to set up 
hybrid constructs [ 43 ], we have shown that hASC may be 
used conveniently to screen several biomaterials, natural 
and synthetic, with potential clinical application. We chose 
a well-known osteoinductive material, HAP, and a less 
characterized material, SiC–PECVD. Recently, many 
manufacturers have developed a coating system of metal 
components, with different types of materials, for example 
for prosthetic use, to improve the osteointegration of the 
devices with the surrounding tissue. So we focused our 
interest on SiC–PECVD, a suitable ameliorative coating 
layer, which can be layered on a metal implant surface and 
is known to be biocompatible [ 44 ]. 
 In a previous study, we compared the differentiation 
effi ciency of hASC either pre-differentiated and then loaded 
on biomaterials, or directly differentiated on biomaterials; no 
signifi cant difference was observed, suggesting that hASC do 
not need a pre-differentiating period to allow them to attach 
to biomaterials and to generate further osteoblast-like cells 
[ 34 ]. This observation allowed us to reduce the time period 
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